Company Information

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE501.25-6.2 (-1.22 %)
PREV CLOSE ( ) 507.45
OPEN PRICE ( ) 510.60
BID PRICE (QTY) 502.05 (28)
OFFER PRICE (QTY) 504.85 (25)
VOLUME 840
TODAY'S LOW / HIGH ( )495.35 510.60
52 WK LOW / HIGH ( ) 248545
NSE
This Company is not listed in NSE
Managing DirectorRamesh Arora
Company SecretaryGurpreet Kaur
Non Executive Independent DirectorKiran Kumar Verma
Pankaj Takkar
Ravi Singh
Kartik Kapur
Prashanth Vellanki
Whole Time DirectorAjay Kumar Arora
Anju Arora
Geeta Arora
Aditya Arora
Incorporation Year : 04-05 1983

Registered Office :

Address : 6th Mile Stone,Village Nagkalan,Majitha Road Amritsar,
Punjab-143601 .

Phone : 08558820862 / 63 / 9915743720

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.